Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration

• Asıl Yazarlar: Shujuan Zhao (Yazar), Xuejiao Hong (Yazar), Jingjing Cao (Yazar), Haixia Cai (Yazar), Song Du (Yazar), Peizhi Ma (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2020-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Patients with non-valvular atrial fibrillation (NVAF) exhibit a high risk of stroke, which is associated with high mortality. Thus, stroke prevention is crucial for the overall management of NVAF. Two categories of drugs, vitamin K antagonist warfarin and non-vitamin K antagonist oral anticoagulants...